These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. An update on treatment advances for the first-line therapy of metastatic colorectal cancer. Lee JJ; Chu E Cancer J; 2007; 13(5):276-81. PubMed ID: 17921724 [TBL] [Abstract][Full Text] [Related]
8. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin. Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749 [TBL] [Abstract][Full Text] [Related]
9. [Targeted biotherapy: a revolution in the management of patients with colorectal cancer?]. Rougier P; Mitry E Gastroenterol Clin Biol; 2009; 33(8-9):672-80. PubMed ID: 19717258 [TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy for metastatic colorectal cancer]. Iwasa S; Shimada Y Gan To Kagaku Ryoho; 2008 Sep; 35(9):1467-74. PubMed ID: 18799899 [TBL] [Abstract][Full Text] [Related]
12. Challenges in the use of epidermal growth factor receptor inhibitors in colorectal cancer. Van Cutsem E Oncologist; 2006 Oct; 11(9):1010-7. PubMed ID: 17030643 [TBL] [Abstract][Full Text] [Related]
13. Is there a third-line therapy for metastatic colorectal cancer? Grothey A Semin Oncol; 2006 Dec; 33(6 Suppl 11):S36-8. PubMed ID: 17178284 [TBL] [Abstract][Full Text] [Related]
14. [Targeting the epidermal growth factor receptor in colorectal cancer: clinical results]. Adenis A; Hebbar M Bull Cancer; 2005 Aug; 92(Spec no):S21-8. PubMed ID: 16387666 [TBL] [Abstract][Full Text] [Related]
15. EGFR targeting therapies: monoclonal antibodies versus tyrosine kinase inhibitors. Similarities and differences. Dassonville O; Bozec A; Fischel JL; Milano G Crit Rev Oncol Hematol; 2007 Apr; 62(1):53-61. PubMed ID: 17324578 [TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms and targeting of colorectal cancer. Vanhoefer U Semin Oncol; 2005 Dec; 32(6 Suppl 8):7-10. PubMed ID: 16360005 [TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor tyrosine kinase inhibitors: present and future role in gastrointestinal cancer treatment: a review. Arnold D; Peinert S; Voigt W; Schmoll HJ Oncologist; 2006 Jun; 11(6):602-11. PubMed ID: 16794239 [TBL] [Abstract][Full Text] [Related]
18. Current status of small-molecule tyrosine kinase inhibitors targeting epidermal growth factor receptor in colorectal cancer. Kuo T; Fisher GA Clin Colorectal Cancer; 2005 Nov; 5 Suppl 2():S62-70. PubMed ID: 16336751 [TBL] [Abstract][Full Text] [Related]
19. Treatment of metastatic colorectal cancer: from cytotoxic agents to molecular agents and multitargeted strategies. Saif MW; Kang SP; Chu E Oncology (Williston Park); 2006 Dec; 20(14 Suppl 10):11-9. PubMed ID: 17354513 [TBL] [Abstract][Full Text] [Related]